home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> Events -> Meetings and Conferences  
 

9th Anti-Infectives Partnering and Deal-making

 
  April 16, 2012  
     
 
GTC Conferences, San Francisco, CA
Jul 09-10, 2012


http://www.gtcbio.com/index.php?option=com_conference&file=program&cn=9th%20Anti-Infectives%20Partnering%20and%20Deal-making&cid=41
 
 
Organized by: GTC Conferences
Invited Speakers:
Neil Abdollahian, MS, MBA
Vice President, Corporate Development
Trius Therapeutics
 
Rosemarie Aurigemma, Ph.D.
Chief, Drug Development Section; Office of Biodefense Research Affairs
DMID, NIAID, NIH
 
Yuan-Hua Ding
Senior Director, External R&D Innovation
Pfizer
 
Michael N. Dudley, Pharm.D., FCCP, FIDSA 
Senior VP, Research & Development and Chief Scientific Officer
Rempex Pharmaceuticals
 
Danielle Drayton
Chief Operating Officer
BioTrends
 
Roger Echols
Principal Member
ID3C - Infectious Disease Drug Development Consulting
 
Barry Eisenstein, M.D., FACP, FIDSA, FAAM
Senior Vice President, Scientific Affairs
Cubist Pharmaceuticals
 
Prabhavathi Fernandes, Ph.D.
Founder, President and Chief Executive Officer 
Cempra Pharmaceuticals
 
Robert Guidos
Vice President, Public Policy & Govt. Relations
Infectious Diseases Society of America (IDSA)
 
Chau Q. Khuong
Private Equity Principal
OrbiMed Advisors
 
Nicholas Landekic
President and Chief Executive Officer
PolyMedix
 
Joseph Larsen, Ph.D.
Chief, Broad Spectrum Antimicrobials (BSA) Program; Division of CBRN Countermeasures
DHHS/ASPR/BARDA
 
Mark Leuchtenberger
President and Chief Executive Officer
Rib-X Pharmaceuticals
 
Stjohn McGrath
Executive Director
Bristol Myers Squibb
 
Kush M. Parmar, MD, Ph.D.
Principal
5AM Ventures
 
Brad Prosek
Senior Director, Corporate Development
Cubist Pharmaceuticals
 
Brad Spellberg, M.D., FIDSA, FACP
Associate Professor, Medicine
Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center
 
Joyce Sutcliffe
Senior Vice President, Biology
Tetraphase Pharmaceuticals
 
Fred C. Tenover, Ph.D., D(ABMM), F(AAM), F(IDSA)
Executive Director, Scientific Affairs
Cepheid
 
Marcel Tigges, Ph.D.
Chief Scientific Officer
BioVersys AG
 
ADVISORY BOARD MEMBERS
 
Yuan-Hua Ding
Senior Director, External R&D Innovation
Pfizer
 
Roger Echols
Principal Member
ID3C - Infectious Disease Drug Development Consulting
 
Barry Hafkin
Chief Medical Officer
Affinium Pharmaceuticals
 
David Harper
Chief Scientific Officer
AmpliPhi Biosciences Corporation
 
Jon Kaiser
Chief Executive Officer
K-PAX Pharmaceuticals
 
Laurenz Kellenberger
Chief Scientific Officer 
Basilea Pharmaceutica
 
Malcolm Kendall
President and Chief Executive Officer
Indel Therapeutics
 
Dennis Molnar
Vice President, Corporate Development
Paratek Pharmaceuticals
 
Rodger Novak 
Head Infectious Disease TSU Global R&D
Sanofi Aventis
 
Neil Ryder
Executive Director, Infectious Diseases
Novartis Institutes for BioMedical Research
 
Glenn Tillotson
Senior Vice President, Medical Affairs
Optimer Pharmaceuticals
 
Deadline for Abstracts: Jun 09, 2012
 
Registration: https://www.gtcbio.com/index.php?option=com_register&cn=9th%20Anti-Infectives%20Partnering%20and%20Deal-making&cid=41
E-mail: infogtcbio@gtcbio.com
 
   
 
home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
 
 

Generated by meetings and positions 5.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995- HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.